Brief: Wave Life Sciences Announces Gsk’S Selection Of Sirna Program To Transition To Gsk For Further Development
30/09/2026 12:32
BRIEF-Wave Life Sciences Announces Gsk’S Selection Of Sirna Program To Transition To Gsk For Further Development Sept 30 (Reuters) - Wave Life Sciences Ltd. WVE.O:
WAVE LIFE SCIENCES ANNOUNCES GSK’S SELECTION OF SIRNA PROGRAM TO TRANSITION TO GSK FOR FURTHER DEVELOPMENT
WAVE LIFE SCIENCES - TO RECEIVE $12 MILLION MILESTONE PAYMENT FOR CANDIDATE SELECTION
WAVE LIFE SCIENCES - ELIGIBLE FOR UP TO $375 MILLION IN MILESTONES PER PROGRAM PLUS TIERED ROYALTIES
Source text: ID:nGNX4SL46c
Further company coverage: WVE.O
((Reuters.Briefs@thomsonreuters.com;;))